Literature DB >> 16601873

Measurement of ATP production in mitochondrial disorders.

R K Shepherd1, N Checcarelli, A Naini, D C De Vivo, S DiMauro, C M Sue.   

Abstract

Mitochondrial diseases are a heterogeneous group of disorders caused by mutations in both nuclear DNA (nDNA) and mitochondrial DNA (mtDNA). Mitochondrial disease leads to impaired respiratory chain function and reduced ATP production. The aim of this study was to compare disturbances in mitochondrial function by measuring ATP synthesis in fibroblasts derived from patients with nDNA and mtDNA defects. Skin fibroblasts derived from 22 patients with either nDNA-related disorders (n = 8) or mtDNA-related disorders (n = 14) were analysed. ATP synthesis was markedly decreased in fibroblasts derived from patients with nDNA-related disorders but only variably so in patients with mtDNA mutations. In fibroblasts with the MELAS 3243A > G mutation, ATP synthesis correlated with mutant load. We believe that the observed differences in ATP production between cell lines derived from patients with nDNA-related disorders and mtDNA-related disorders may help in the assessment of patients with undiagnosed mitochondrial disease. The clinical comparisons observed in patients with nDNA- and mtDNA-related disorders may be explained by differences in the disturbance of ATP synthesis measured in the two conditions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16601873     DOI: 10.1007/s10545-006-0148-8

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  19 in total

1.  The use of lymphocytes to screen for oxidative phosphorylation disorders.

Authors:  Barbara J Marriage; M Thomas Clandinin; Ian M MacDonald; D Moira Glerum
Journal:  Anal Biochem       Date:  2003-02-01       Impact factor: 3.365

2.  Rapid detection of the A----G(8344) mutation of mtDNA in Italian families with myoclonus epilepsy and ragged-red fibers (MERRF).

Authors:  M Zeviani; P Amati; N Bresolin; C Antozzi; G Piccolo; A Toscano; S DiDonato
Journal:  Am J Hum Genet       Date:  1991-02       Impact factor: 11.025

3.  Biochemical-clinical correlation in patients with different loads of the mitochondrial DNA T8993G mutation.

Authors:  Valerio Carelli; Alessandra Baracca; Silvia Barogi; Francesco Pallotti; Maria Lucia Valentino; Pasquale Montagna; Massimo Zeviani; Antonella Pini; Giorgio Lenaz; Agostino Baruzzi; Giancarlo Solaini
Journal:  Arch Neurol       Date:  2002-02

4.  Complex approach to prenatal diagnosis of cytochrome c oxidase deficiencies.

Authors:  J Houstek; P Klement; J Hermanská; H Antonická; H Houstková; L Stratilová; R J Wanders; J Zeman
Journal:  Prenat Diagn       Date:  1999-06       Impact factor: 3.050

5.  A novel deficiency of mitochondrial ATPase of nuclear origin.

Authors:  J Houstek; P Klement; D Floryk; H Antonická; J Hermanská; M Kalous; H Hansíková; H Hout'ková; S K Chowdhury; T Rosipal; S Kmoch; L Stratilová; J Zeman
Journal:  Hum Mol Genet       Date:  1999-10       Impact factor: 6.150

6.  Bioenergetic consequences of accumulating the common 4977-bp mitochondrial DNA deletion.

Authors:  W K Porteous; A M James; P W Sheard; C M Porteous; M A Packer; S J Hyslop; J V Melton; C Y Pang; Y H Wei; M P Murphy
Journal:  Eur J Biochem       Date:  1998-10-01

7.  Defects in mitochondrial protein synthesis and respiratory chain activity segregate with the tRNA(Leu(UUR)) mutation associated with mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes.

Authors:  M P King; Y Koga; M Davidson; E A Schon
Journal:  Mol Cell Biol       Date:  1992-02       Impact factor: 4.272

8.  Analysis of cybrids harboring MELAS mutations in the mitochondrial tRNA(Leu(UUR)) gene.

Authors:  Y Koga; M Davidson; E A Schon; M P King
Journal:  Muscle Nerve Suppl       Date:  1995

9.  Altered properties of mitochondrial ATP-synthase in patients with a T-->G mutation in the ATPase 6 (subunit a) gene at position 8993 of mtDNA.

Authors:  J Houstĕk; P Klement; J Hermanská; H Houstková; H Hansíková; C Van den Bogert; J Zeman
Journal:  Biochim Biophys Acta       Date:  1995-06-09

10.  Cytoplasmic transfer of the mtDNA nt 8993 T-->G (ATP6) point mutation associated with Leigh syndrome into mtDNA-less cells demonstrates cosegregation with a decrease in state III respiration and ADP/O ratio.

Authors:  I Trounce; S Neill; D C Wallace
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-30       Impact factor: 11.205

View more
  8 in total

1.  Decreased hippocampal expression of calbindin D28K and cognitive impairment in MELAS.

Authors:  Valentina Emmanuele; Angels Garcia-Cazorla; Hua-Bin Huang; Jorida Coku; Beatriz Dorado; Etty P Cortes; Kristin Engelstad; Darryl C De Vivo; Salvatore Dimauro; Eduardo Bonilla; Kurenai Tanji
Journal:  J Neurol Sci       Date:  2012-04-05       Impact factor: 3.181

2.  Enhanced glycolysis and GSK3 inactivation promote brain metabolic adaptations following neuronal mitochondrial stress.

Authors:  Sofia Garcia; Amy Saldana-Caboverde; Mir Anwar; Ami Pravinkant Raval; Nadee Nissanka; Milena Pinto; Carlos Torres Moraes; Francisca Diaz
Journal:  Hum Mol Genet       Date:  2022-03-03       Impact factor: 5.121

3.  Characterization of human GTPBP3, a GTP-binding protein involved in mitochondrial tRNA modification.

Authors:  Magda Villarroya; Silvia Prado; Juan M Esteve; Miguel A Soriano; Carmen Aguado; David Pérez-Martínez; José I Martínez-Ferrandis; Lucía Yim; Victor M Victor; Elvira Cebolla; Asunción Montaner; Erwin Knecht; M-Eugenia Armengod
Journal:  Mol Cell Biol       Date:  2008-10-13       Impact factor: 4.272

4.  Mutant Parkin impairs mitochondrial function and morphology in human fibroblasts.

Authors:  Anne Grünewald; Lisa Voges; Aleksandar Rakovic; Meike Kasten; Himesha Vandebona; Claudia Hemmelmann; Katja Lohmann; Slobodanka Orolicki; Alfredo Ramirez; Anthony H V Schapira; Peter P Pramstaller; Carolyn M Sue; Christine Klein
Journal:  PLoS One       Date:  2010-09-27       Impact factor: 3.240

5.  Parkinson's disease-associated human ATP13A2 (PARK9) deficiency causes zinc dyshomeostasis and mitochondrial dysfunction.

Authors:  Jin-Sung Park; Brianada Koentjoro; David Veivers; Alan Mackay-Sim; Carolyn M Sue
Journal:  Hum Mol Genet       Date:  2014-01-07       Impact factor: 5.121

6.  Encompassing ATP, DNA, insulin, and protein content for quantification and assessment of human pancreatic islets.

Authors:  Meirigeng Qi; Shiela Bilbao; Elena Forouhar; Fouad Kandeel; Ismail H Al-Abdullah
Journal:  Cell Tissue Bank       Date:  2017-09-15       Impact factor: 1.522

7.  Dysfunctional pancreatic cells differentiated from induced pluripotent stem cells with mitochondrial DNA mutations.

Authors:  Seongjun So; Song Lee; Yeonmi Lee; Jongsuk Han; Soonsuk Kang; Jiwan Choi; Bitnara Kim; Deokhoon Kim; Hyun-Ju Yoo; In-Kyong Shim; Ju-Yun Oh; Yu-Na Lee; Song-Cheol Kim; Eunju Kang
Journal:  BMB Rep       Date:  2022-09       Impact factor: 5.041

8.  Development of a human mitochondrial oligonucleotide microarray (h-MitoArray) and gene expression analysis of fibroblast cell lines from 13 patients with isolated F1Fo ATP synthase deficiency.

Authors:  Alena Cízková; Viktor Stránecký; Robert Ivánek; Hana Hartmannová; Lenka Nosková; Lenka Piherová; Markéta Tesarová; Hana Hansíková; Tomás Honzík; Jirí Zeman; Petr Divina; Andrea Potocká; Jan Paul; Wolfgang Sperl; Johannes A Mayr; Sara Seneca; Josef Houstĕk; Stanislav Kmoch
Journal:  BMC Genomics       Date:  2008-01-25       Impact factor: 3.969

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.